Physician Office In Vitro Diagnostic (IVD) Test Markets

12 Jan 2023

This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies.  Physicians’ office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments that yield rapid diagnostic results.

Information and data appearing in this report include:

  • Macroeconomic, demographic, epidemiological, and healthcare indicators that influence product demand patterns and growth opportunities
  • Projected global product demand by type and technology for the years 2022 through 2027
  • The projected value of regional and selected national markets for physicians’ office laboratory IVD products in each of the forecast years (2022 through 2027). 

The report also includes profiles of the major producers of physicians’ office laboratory IVD products.

Report coverage extends to worldwide markets, but focuses on the United States and other developed countries. The majority of physicians’ practices in the developing world are located in hospitals and outpatient clinics and do not engage actively in patient testing.     

In addition, the report profiles key companies in the market, including:

  • Abbott Laboratories
  • Abingdon Health
  • ACON Laboratories, Inc.
  • ArcDia International Oy Ltd.
  • Axis-Shield Diagnostics Ltd.
  • Becton Dickinson and Company (BD)
  • binx health, inc.
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • Biomerica, Inc.
  • bioMérieux S.A.
  • Boule Diagnostics AB
  • Cardinal Health, Inc.
  • Carolina Liquid Chemistries Corporation
  • Chembio Diagnostics, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • EKF Diagnostics Holdings plc
  • Exact Sciences Corporation
  • genedrive plc
  • HORIBA Ltd.
  • Immunostics, Inc.
  • MedMira, Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies
  • PTS Diagnostics
  • QuantuMDx Group Ltd.
  • QuidelOrtho Corporation
  • Roche
  • Siemens Healthcare GmbH (Siemens Healthineers)
  • Stago Group
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech plc
  • Werfen

Page Count: 178